<?xml version="1.0" encoding="UTF-8"?>
<p>Chikungunya studies were primarily conducted in Africa (46%) and Asia (24%). The most represented countries were Kenya, with six studies, and India [
 <xref rid="pntd.0006533.ref123" ref-type="bibr">123</xref>,
 <xref rid="pntd.0006533.ref125" ref-type="bibr">125</xref>,
 <xref rid="pntd.0006533.ref138" ref-type="bibr">138</xref>,
 <xref rid="pntd.0006533.ref152" ref-type="bibr">152</xref>], Madagascar [
 <xref rid="pntd.0006533.ref128" ref-type="bibr">128</xref>,
 <xref rid="pntd.0006533.ref128" ref-type="bibr">128</xref>,
 <xref rid="pntd.0006533.ref128" ref-type="bibr">128</xref>,
 <xref rid="pntd.0006533.ref128" ref-type="bibr">128</xref>] and French Polynesia [
 <xref rid="pntd.0006533.ref114" ref-type="bibr">114</xref>,
 <xref rid="pntd.0006533.ref163" ref-type="bibr">163</xref>], with four studies (
 <xref ref-type="fig" rid="pntd.0006533.g003">Fig 3C</xref>).
</p>
